Barclays’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Sell |
12,710
-94,025
| -88% | -$66.6K | ﹤0.01% | 4164 |
|
|
2025
Q1 | $107K | Sell |
106,735
-60,087
| -36% | -$60.2K | ﹤0.01% | 3663 |
|
|
2024
Q4 | $1.77M | Buy |
166,822
+37,612
| +29% | +$398K | ﹤0.01% | 2279 |
|
|
2024
Q3 | $1.71M | Buy |
129,210
+100,678
| +353% | +$1.33M | ﹤0.01% | 2295 |
|
|
2024
Q2 | $280K | Buy |
28,532
+18,110
| +174% | +$178K | ﹤0.01% | 2857 |
|
|
2024
Q1 | $143K | Sell |
10,422
-10,117
| -49% | -$139K | ﹤0.01% | 3503 |
|
|
2023
Q4 | $350K | Buy |
+20,539
| New | +$350K | ﹤0.01% | 3214 |
|